Sweet Relief!

New QR Cream™ with plant-powered mannitol

relieves aching, tingling or burning pain

Clinically proven cream features 30% mannitol + 1.25% menthol—no prescription required.

Vancouver—Launch September 2020—Can mannitol, a plant-derived ingredient commonly used in chewing gum, cosmetics and baking, be the solution to chronic pain? Two Vancouver-based female medical professionals with a special interest in pain management say yes.  

After almost a decade of research and testing, QR (Quick Relief) Cream™, the first OTC pain-relief cream powered by breakthrough ingredient mannitol, launched to U.S. consumers this month. Previously delivered only by injection, mannitol can now be applied directly to painful areas—no prescription required.

Featuring 30% mannitol + 1.25% menthol, this non-greasy, narcotic-free cream relieves pain or discomfort that is mediated by superficial cutaneous (skin) nerves, including aching, tingling or burning pain of the neck, back, shoulder, wrist, finger, thigh, knee and foot, and the itch associated with poison ivy and psoriasis. It is recommend to relieve pain from arthritis, neuropathy, migraines, shingles, burns and pain and itch from insect stings/bites.

This revolutionary pain cream was developed by Hélène Bertrand, MD, CM, a family physician and scientific researcher, and Marylene Kyriazis, B. Pharm, Pharm D, a clinical pharmacist with a focus on pain management and palliative care. In 2010, Dr. Bertrand started working with patients who were suffering from pain. When she injected mannitol around inflamed nerves, the pain would frequently disappear before she removed the needle from the skin. She believed that it might be possible to use a skin-penetrating cream to deliver mannitol to those nerves. She began collaborating with Dr. Kyriazis, and QR Cream™ was born.

“Common topical pain relievers work by reducing inflammation, numbing the pain or irritating the skin to distract the brain from pain,” explains Dr. Bertrand. “But QR Cream™ works in a new way by interrupting the pain signal from the nerve to the brain. Clinical studies have shown that QR Cream™ relieves pain better than acetaminophen, narcotics and anti-inflammatories taken by mouth.”

Adds Dr. Kyriazis, “QR Cream™ works without contraindications or drug interactions. Results are cumulative—the more you use it, the less you need it.”

MRSP is $49.95 with a special intro price available. QR Cream™ is patented in the United States and Canada and approved by Health Canada as a natural health product. Mannitol is approved by the U.S. FDA for topical pain relief.

The first product from MaryHelene Enterprises, Inc., QR Cream™ is available through select retailers and at qrcream.com. For more information and clinical studies, visit qrcream.com.

To receive a sample sachet, if you are in Canada, go to www.qrcream.com "BUY NOW"